Search results
Results From The WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
The first response was to hold all paper stock certificates in one centralized location, and automate the process by keeping electronic records of all certificates and securities clearing and settlement (changes of ownership and other securities transactions). [13] One problem was state laws requiring brokers to deliver certificates to investors.
Ownership % Acquisition Date (YYYY/MM/DD) Acquisition Price Notes Acme Brick Company: Materials and Construction 100% 2000/08/01 [2] ~$600 Million ($4,392.65 Million 2017) [3] [4] Alleghany Corporation: Insurance 100% 2022/10/19 [5] $11.6 billion [6] Included Alleghany subsidiary Kentucky Trailer, which designs and manufacturers trailers AltaLink
Institutional Shareholder Services Inc. ( ISS) is a proxy advisory firm. Hedge funds, mutual funds and similar organizations that own shares of multiple companies pay ISS to advise (and often vote their shares) regarding share holder votes. As the leading firm in the industry, ISS commands a 48 percent market share as of 2021, with its nearest ...
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.